載入...
Clinical Utilization of Blinatumomab and Inotuzumab Immunotherapy in Children with Relapsed or Refractory B-Acute Lymphoblastic Leukemia
BACKGROUND: The treatment paradigm for patients with relapsed/refractory B-cell acute lymphoblastic leukemia (rrALL) has been revolutionized given recent clinical trials demonstrating remarkable success of immunotherapies and leading to drug approvals by United States and European agencies. We repor...
Na minha lista:
| 發表在: | Pediatr Blood Cancer |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7688575/ https://ncbi.nlm.nih.gov/pubmed/33098744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.28718 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|